TofisopamThird Party Manufacturing in India

Tofisopam works by selectively binding to specific central sites, functioning as an atypical benzodiazepine derivative that lacks classical sedative, anticonvulsant, or muscle relaxant actions. It modulates autonomic nervous system functions and acts as a mild phosphodiesterase inhibitor to relieve psychovegetative symptoms. Unlike traditional 1,4-benzodiazepines, it does not induce physical dependence, sedation, or cognitive impairment. It is highly effective and well-tolerated for daytime anxiolysis.

Therapeutic Uses

• Anxiety Disorders: Treatment of mild to moderate anxiety, tension, and associated autonomic nervous system disturbances.
• Alcohol Withdrawal: Alleviation of vegetative and neuro-psychic symptoms during acute withdrawal phases.

Why Manufacturers Choose Tofisopam

Tofisopam third party manufacturing in India is a high-yield opportunity for marketing companies targeting contemporary psychiatric portfolios with lower dependency risks. Our WHO-GMP compliant manufacturing partners deploy advanced analytics to monitor active chemical polymorphism and guarantee consistent therapeutic bioavailability. Celesta stands as a premium supplier, ensuring stable market ready batches tailored for strategic brand positioning.